Proliferation of human lung cancer in an orthotopic transplantation mouse model

Kang,Yun; Omura,Motoko; Suzuki,Akiko; Theeraladanon,Chumpol; Oka,Takashi; Nakagami,Yoshihiro; Suzuki,Atsushi; Nagashima,Yoji; Inoue,Tomio

doi:10.3892/etm_00000073

Proliferation of human lung cancer in an orthotopic transplantation mouse model

Authors:
- Yun Kang
- Motoko Omura
- Akiko Suzuki
- Chumpol Theeraladanon
- Takashi Oka
- Yoshihiro Nakagami
- Atsushi Suzuki
- Yoji Nagashima
- Tomio Inoue
View Affiliations

Affiliations: Department of Radiology, Graduate School of Medicine, Yokohama City University, Kanagawa-ken 236-0004, Japan. kangy@yokohama-cu.ac.jp
Published online on: May 1, 2010 https://doi.org/10.3892/etm_00000073
Pages: 471-475

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The objective of this study was to clarify the growth and proliferation style of human lung cancer grown in an orthotopic transplantation model. The human lung squamous cell carcinoma SQ5 and adenocarcinoma A549 cell lines were used. Tumor cells suspended in serum-free medium were directly injected into the main bronchi of anesthetized female Balb/c athymic nude mice with simultaneous administration of 0.01 M ethylenediaminetetraacetic acid. Bromodeoxyuridine was injected into mice 20 min before sacrifice. Lung tissue with tumor nodules and subcutaneous tumors were fixed and confirmed by histological examinations. Bromodeoxyuridine-labeled cells in the tumor area were counted, and the proliferation index was calculated. Lung tumor colonies of various sizes were obtained in the SQ5- and A549-cell orthotopically transplanted mice. Orthotopic SQ5 tumors whose minor diameter was 40-700 µm and major diameter was 80-830 µm showed no definite necrosis. Orthotopic SQ5 tumors whose minor diameter was 540-5,200 µm and major diameter was 600-6,100 µm showed definite necrosis in the tumor center. Similar results were also found in the orthotopic A549 tumors. The proliferation index was 7.38 (3.03)/10.63 (3.10) in the orthotopic SQ5 tumors with/without necrosis and 6.99 (2.10) in the subcutaneous SQ5 tumors with necrosis, respectively. The proliferation index was 2.70 (0.88)/3.53 (1.70) in the orthotopic A549 tumors with/without necrosis and 3.91 (0.63) in the subcutaneous A549 tumors with necrosis, respectively. The data suggest that this orthotopic transplantation model may provide the proper organ microenvironment for lung cancer growth and may be suitable for the target therapy research of human lung cancer.

View Figures

View References

1.	American Cancer Society: Cancer facts and figures 2002. American Cancer Society; Atlanta, GA: 2002
2.	Vital statistics of Japan, Statistics and Information Dept., Minister’s Secretarial, Ministry of Health, Labor and Welfare, 2001.
3.	Onn A, Isobe T, Itasaka S, Wu W, O’Reilly MS, Ki Hong W, Fidler IJ and Herbst RS: Development of an orthotopic model to study the biology and therapy of primary human lung cancer in nude mice. Clin Cancer Res. 9:5532–5539. 2003.PubMed/NCBI
4.	Kuo TH, Kubota T, Watanabe M, Furukawa T, Kase S, Tanino H, Saikawa Y, Ishibiki K, Kitajima M and Hoffman RM: Site-specific chemosensitivity of human small-cell lung carcinoma growing orthotopically compared to subcutaneously in SCID mice: the importance of orthotopic models to obtain relevant drug evaluation data. Anticancer Res. 13:627–630. 1993.
5.	Wilmanns C, Fan D, O’Brian CA, Bucana CD and Fidler IJ: Orthotopic and ectopic organ environments differentially influence the sensitivity of murine colon carcinoma cells to doxorubicin and 5-fluorouracil. Int J Cancer. 52:98–104. 1992. View Article : Google Scholar
6.	Fidler IJ, Wilmanns C, Staroselsky A, Radinsky R, Dong Z and Fan D: Modulation of tumor cell response to chemotherapy by the organ environment. Cancer Metastasis Rev. 13:209–222. 1994. View Article : Google Scholar : PubMed/NCBI
7.	Camphausen K, Purow B, Sproull M, Scott T, Ozawa T, Deen DF and Tofilon PJ: Influence of in vivo growth on human glioma cell line gene expression: convergent profiles under orthotopic conditions. Proc Natl Acad Sci USA. 102:8287–8292. 2005. View Article : Google Scholar : PubMed/NCBI
8.	Kang Y, Omura M, Suzuki A, Oka T, Nakagami Y, Cheng C, Nagashima Y and Inoue T: Development of an orthotopic transplantation model in nude mice that simulates the clinical features of human lung cancer. Cancer Sci. 97:996–1001. 2006. View Article : Google Scholar : PubMed/NCBI
9.	Omura M, Torigoe S, Kurihara H, Matsubara S and Kubota N: Comparison between fractionated high dose rate irradiation and continuous low dose rate irradiation in spheroids. Acta Oncol. 37:681–686. 1998. View Article : Google Scholar : PubMed/NCBI
10.	Terry NH, Brinkley J, Doig AJ, Ma J, Patel N, White RA, Mahajan N and Kang Y: Cellular kinetics of murine lung: model system to determine basis for radioprotection with keratinocyte growth factor. Int J Radiat Oncol Biol Phys. 58:435–444. 2004. View Article : Google Scholar : PubMed/NCBI
11.	Knighton D, Ausprunk D, Tapper D and Folkman J: Avascular and vascular phases of tumour growth in the chick embryo. Br J Cancer. 35:347–356. 1977. View Article : Google Scholar : PubMed/NCBI
12.	Lien WM and Ackerman NB: The blood supply of experimental liver metastases. II. A microcirculatory study of the normal and tumor vessels of the liver with the use of perfused silicone rubber. Surgery. 68:334–340. 1970.PubMed/NCBI
13.	Jain RK: Delivery of molecular medicine to solid tumors: lessons from in vivo imaging of gene expression and function. J Control Release. 74:7–25. 2001. View Article : Google Scholar : PubMed/NCBI
14.	Leo C, Giaccia AJ and Denko NC: The hypoxic tumor microenvironment and gene expression. Semin Radiat Oncol. 14:207–214. 2004. View Article : Google Scholar : PubMed/NCBI
15.	Morishita C, Jin E, Kikuchi M, Egawa S, Fujiwara M, Ohaki Y, Ghazizadeh M, Takemura T and Kawanami O: Angiogenic switching in the alveolar capillaries in primary lung adenocarcinoma and squamous cell carcinoma. J Nippon Med Sch. 74:344–354. 2007. View Article : Google Scholar : PubMed/NCBI
16.	Hwang RF, Moore T, Arumugam T, Ramachandran V, Amos KD, Rivera A, Ji B, Evans DB and Logsdon CD: Cancer-associated stromal fibroblasts promote pancreatic tumor progression. Cancer Res. 68:918–926. 2008. View Article : Google Scholar : PubMed/NCBI
17.	Sun B, Zhang S, Zhang D, Gu Y, Zhang W and Zhao X: The influence of different microenvironments on melanoma invasiveness and microcirculation patterns: an animal experiment study in the mouse model. J Cancer Res Clin Oncol. 133:979–985. 2007. View Article : Google Scholar : PubMed/NCBI
18.	Onn A, Isobe T, Wu W, Itasaka S, Shintani T, Shibuya K, Kenji Y, O’reilly MS, Fidler IJ and Herbst RS: Epidermal growth factor receptor tyrosine kinase inhibitor does not improve paclitaxel effect in an orthotopic mouse model of lung cancer. Clin Cancer Res. 10:8613–8619. 2004. View Article : Google Scholar : PubMed/NCBI